Search research articles
Contact Us
Filters
Showing results (361-370 of 402) with videos related to
Page
of 41
Sort By:
Gynecologic Oncology
|
May 22, 2017
Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes
Ane Gerda Z Eriksson, Ashley Graul, Miao C Yu, et al.
Cancer
|
July 14, 2011
A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma
Oliver Zivanovic, Lindsay M Jacks, Alexia Iasonos, et al.
Cancer
|
June 11, 2005
Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-up
Noah D Kauff, Karen E Hurley, Martee L Hensley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2003
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations
Douglas A Levine, Peter A Argenta, Cindy J Yee, et al.
Gynecologic Oncology
|
December 14, 2011
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer
Joyce N Barlin, Changhong Yu, Emily K Hill, et al.
Gynecologic Oncology
|
August 8, 2006
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer
Eric L Eisenhauer, Nadeem R Abu-Rustum, Yukio Sonoda, et al.
Gynecologic Oncology
|
February 24, 2009
Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?
Nadeem R Abu-Rustum, Fady Khoury-Collado, Neeta Pandit-Taskar, et al.
Gynecologic Oncology
|
February 1, 2008
Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer
Destin Black, Douglas A Levine, Linda Nicoll, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 16, 2013
Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment
Joyce N Barlin, Robert A Soslow, Megan Lutz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1998
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer
C Aghajanian, D Fennelly, F Shapiro, et al.
Page
of 41
Search research articles
Search
Showing results (361-370 of 402) with videos related to
Sort By:
Page
of 41
Gynecologic Oncology
|
May 22, 2017
Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes
Ane Gerda Z Eriksson, Ashley Graul, Miao C Yu, et al.
Cancer
|
July 14, 2011
A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma
Oliver Zivanovic, Lindsay M Jacks, Alexia Iasonos, et al.
Cancer
|
June 11, 2005
Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-up
Noah D Kauff, Karen E Hurley, Martee L Hensley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2003
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations
Douglas A Levine, Peter A Argenta, Cindy J Yee, et al.
Gynecologic Oncology
|
December 14, 2011
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer
Joyce N Barlin, Changhong Yu, Emily K Hill, et al.
Gynecologic Oncology
|
August 8, 2006
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer
Eric L Eisenhauer, Nadeem R Abu-Rustum, Yukio Sonoda, et al.
Gynecologic Oncology
|
February 24, 2009
Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?
Nadeem R Abu-Rustum, Fady Khoury-Collado, Neeta Pandit-Taskar, et al.
Gynecologic Oncology
|
February 1, 2008
Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer
Destin Black, Douglas A Levine, Linda Nicoll, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 16, 2013
Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment
Joyce N Barlin, Robert A Soslow, Megan Lutz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1998
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer
C Aghajanian, D Fennelly, F Shapiro, et al.
Page
of 41